PatientMatch — Privacy-first clinical trial discovery

Showing 1–24 of 69 trials

Enrolling now

Nationwide

A First-in-Human (FIH) Trial to Evaluate VVD-130037 in People With Advanced Solid Tumors

Vividion Therapeutics, Inc.

Ph 1·~8yr·8 sites in FL, MN, TN +2

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

SEED Therapeutics, Inc.

Ph 1·~4yr·6 sites in CA, MA, NY +1

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib

National Cancer Institute (NCI)

Ph 1/2·~5yr·1 site in MD

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Marengo Therapeutics, Inc.

Ph 1/2·~4yr·18 sites in CA, CO, FL +11

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of BG-C477 in Participants With Advanced Solid Tumors

BeOne Medicines

Ph 1·~4yr·5 sites in CA, CT, KS +2

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of JNJ-87890387 for Advanced Solid Tumors

Janssen Research & Development, LLC

Ph 1·~5yr·2 sites in MI, TN

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors

FoRx Therapeutics AG

Ph 1·~3yr·8 sites in CA, MI, MO +3

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707)

Eikon Therapeutics

Ph 1/2·~4yr·6 sites in CO, FL, MA +2

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of PHST001 in Advanced Solid Tumors

Pheast Therapeutics

Ph 1·~6yr·10 sites in CA, CT, IL +5

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

Merck Sharp & Dohme LLC

Ph 1/2·~6yr·4 sites in AL, FL, NJ +1

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy

AstraZeneca

Ph 1·~4yr·3 sites in NC, TX, VA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

EMD Serono Research & Development Institute, Inc.

Ph 1·~3yr·4 sites in CT, NC, TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

First-in-Human Study of OKI-219

OnKure, Inc.

Ph 1·~3yr·13 sites in CA, CO, MA +6

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

JAB-23E73 Trial

Jacobio Pharmaceuticals Co., Ltd.

Ph 1/2·~3yr·4 sites in MN, MO, OH +1

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Safety and Preliminary Anti-Tumor Activity of TYRA-430

Tyra Biosciences, Inc

Ph 1·~3yr·9 sites in CA, KS, MA +4

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

Revolution Medicines, Inc.

Ph 1·~3yr·5 sites in MI, TX, VA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

TAPUR Trial

American Society of Clinical Oncology

Ph 2·~13yr·174 sites in AL, AZ, CA +25

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors

Genmab

Ph 1·2 sites in MI, NY

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A First-In Human (FIH) Trial of REGN10597 Medicine

Regeneron Pharmaceuticals

Ph 1/2·~5yr·11 sites in CA, CT, IL +5

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

MediLink Therapeutics (Suzhou) Co., Ltd.

Ph 1·~5yr·11 sites in CO, CT, FL +3

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of ASKG915 in Patients With Selected Advanced Solid Tumors

AskGene Pharma, Inc.

Ph 1/2·~5yr·2 sites in NY, PA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors

Bristol-Myers Squibb

Ph 1/2·~4yr·7 sites in CA, CO, NC +3

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

Ottimo Pharma Limited

Ph 1/2·~3yr·4 sites in MA, MI, TX +1

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of PHN-012 in Patients With Advanced Solid Tumors

Pheon Therapeutics

Ph 1·~3yr·11 sites in CA, DC, MA +6

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify